Catalyst Wire Dossier Catalyst Wire Dossier

liposomal lurtotecan

lurtotecan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for liposomal lurtotecan, covering 2012-07-24 to 2012-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer [Phase 2]

See pricing